# El Salvador Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore El Salvador HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: El Salvador (SLV) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $18.0M - Products: 23 - Buyer markets: 18 - Average CAGR: +9.3% - Global sector size: $370.0B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $260.0B | $13.1M | $94.6B | -12.6% | 16 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $23.2B | $2.3M | $15.0B | +8.9% | 7 | +0.0% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.8B | $100.9K | $10.2B | +12.5% | 3 | +0.0% | | HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $12.1B | $291.3 | $5.2B | -21.3% | 2 | +0.0% | | HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $5.8B | $356.6 | $4.6B | -2.6% | 1 | +0.0% | | HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $8.5B | $353.0K | $4.3B | +4.5% | 1 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $10.2B | $95.2K | $4.1B | +14.2% | 4 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $11.0B | $2.0K | $4.0B | +2.9% | 4 | +0.0% | | HS 330300 - Perfumes and toilet waters | $7.0B | $105.1K | $3.6B | +40.8% | 2 | +0.0% | | HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $2.0B | $55.2 | $2.3B | +489.9% | 1 | +0.0% | | HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $32.5K | $2.2B | +1.8% | 2 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $53.6K | $2.1B | +4.6% | 2 | +0.0% | | HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $250.5 | $2.0B | -7.6% | 1 | +0.0% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $21.3 | $1.0B | -7.6% | 1 | +0.0% | | HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $78.2 | $803.3M | -23.6% | 1 | +0.0% | | HS 300431 - Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale | $952.3M | $142.8 | $753.2M | +33.8% | 1 | +0.0% | | HS 281410 - Ammonia: anhydrous | $1.1B | $11.6 | $748.4M | -69.5% | 1 | +0.0% | | HS 300432 - Medicaments: containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | $1.9B | $181.0 | $746.4M | -5.0% | 1 | +0.0% | | HS 380893 - Herbicides, anti-sprouting products and plant-growth regulators: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $957.5M | $962.1K | $728.9M | +42.0% | 1 | +0.1% | | HS 284440 - Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | $927.2M | $502.4 | $685.2M | +12.8% | 1 | +0.0% | | HS 340600 - Candles, tapers and the like | $1.0B | $740.3K | $639.9M | +13.0% | 1 | +0.1% | | HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $1.0B | $172.4K | $638.5M | +10.5% | 1 | +0.0% | | HS 330749 - Perfumes and deodorizors: perfuming or deodorizing preparations for rooms, (excluding those which operate by burning) | $676.1M | $107.0 | $579.1M | +13.2% | 1 | +0.0% | ## Best markets - USA, Puerto Rico and US Virgin Islands (USA): $53.5B calculated opportunity across 19 products. - Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products. - Germany (DEU): $16.9B calculated opportunity across 8 products. - Canada (CAN): $9.0B calculated opportunity across 6 products. - Belgium (BEL): $7.0B calculated opportunity across 1 products. - Mexico (MEX): $6.9B calculated opportunity across 3 products. - Netherlands (NLD): $5.9B calculated opportunity across 2 products. - Spain (ESP): $5.9B calculated opportunity across 2 products. - France (FRA): $5.5B calculated opportunity across 4 products. - Italy (ITA): $4.9B calculated opportunity across 1 products. - United Kingdom (GBR): $4.1B calculated opportunity across 1 products. - Ireland (IRL): $3.2B calculated opportunity across 1 products. ## Growth stars - HS 382600: +489.9% average CAGR, $2.3B calculated opportunity. - HS 380893: +42.0% average CAGR, $728.9M calculated opportunity. - HS 330300: +40.8% average CAGR, $3.6B calculated opportunity. - HS 300431: +33.8% average CAGR, $753.2M calculated opportunity. - HS 330499: +14.2% average CAGR, $4.1B calculated opportunity. - HS 330749: +13.2% average CAGR, $579.1M calculated opportunity. - HS 340600: +13.0% average CAGR, $639.9M calculated opportunity. - HS 284440: +12.8% average CAGR, $685.2M calculated opportunity. - HS 330210: +12.5% average CAGR, $10.2B calculated opportunity. - HS 381512: +10.5% average CAGR, $638.5M calculated opportunity. ## Diversification opportunities - HS 300490: 16 buyer markets, $94.6B calculated opportunity. - HS 382499: 7 buyer markets, $15.0B calculated opportunity. - HS 330499: 4 buyer markets, $4.1B calculated opportunity. - HS 382200: 4 buyer markets, $4.0B calculated opportunity. - HS 330210: 3 buyer markets, $10.2B calculated opportunity. - HS 300439: 2 buyer markets, $5.2B calculated opportunity. - HS 330300: 2 buyer markets, $3.6B calculated opportunity. - HS 300390: 2 buyer markets, $2.2B calculated opportunity. - HS 340220: 2 buyer markets, $2.1B calculated opportunity. - HS 293499: 1 buyer markets, $4.6B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.